Abstract Background There is a high incidence of adverse effects from non-steroidal antiinflammatory drugs (NSAIDs) in Thailand, but patients' perceptions and knowledge of NSAID risks is unknown. Objective This study aims to assess patients' perceptions and knowledge of NSAID risks and factors affecting them. Setting University hospital in North-East of Thailand. Method A Cross-sectional study conducted over 4 months, using a self-administered questionnaire. Patients prescribed NSAIDs for at least one month duration from orthopaedic clinic were recruited using systematic random sampling. Main outcome measure Patients' perceptions on NSAID risks, knowledge on risk factors, and their associated factors. Results A total of 474 questionnaires were assessed. Overall perceptions of risks was low (scoring below five on a 0-10 visual analogue scale), with risks associated with the renal system scoring highest. Perceived risk of gastrointestinal problems differed between patients using non-selective and selective NSAIDs (3.47 ± 2.75 vs 2.06 ± 2.98; P \ 0.001). Receiving side effect information from a health professional was associated with higher risk perception. Most patients (80 %) identified high doses, renal disease and gastrointestinal ulcer increased risks of NSAIDs, but fewer than half recognized that use in the elderly, multiple NSAID use, drinking, hypertension and cardiovascular disease also increased risk of adverse events. Having underlying diseases and receiving side effect information were associated with 1.6-2.0 fold increased knowledge of NSAID risks. Conclusion Perceptions and knowledge concerning NSAID risks was generally low in Thai patients, but higher in those who had received side effect information. Risk-related information should be widely provided, especially in high-risk patients.
Introduction
Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used and effective for pain and inflammation, but carry a high risk of side effects [1] . They were also mostly prescribed and used as self-medication for management of musculoskeletal problems in orthopaedic patients [2] [3] [4] . Despite this, they are frequently prescribed to patients with underlying factors increasing risk, such as the elderly, and those with co-morbidities or multiple drug use [4, 5] . Moreover studies in a range of countries suggest that patients have little awareness of the risk of these medicines [6] [7] [8] [9] [10] [11] [12] [13] . In one study only a third of Turkish patients with osteoarthritis were aware of side effects of NSAIDs, with 85.4 % of these identifying only gastrointestinal risks [8] . Almost half the patients surveyed in a Malaysian rheumatology clinic had no knowledge of NSAID side effects [14] , while patients in a Danish rheumatology clinic showed lack of awareness of underlying factors which can increase risks of side effects [9] . However we found no studies exploring knowledge of NSAID risks among orthopaedic patients. Previous studies from several countries also suggest frequent inappropriate use of over the counter NSAIDs, as well as poor knowledge of risks associated with these agents [7, 11, 15] . One such study, conducted in Thailand, found that NSAID use was inversely related to knowledge about NSAIDs but positively associated with obtaining analgesics from community pharmacies [15] .
NSAID use in Thailand is associated with adverse events, as elsewhere. A retrospective study involving 12,591 NSAID prescriptions from 1030 patients found a total of 78 gastrointestinal events and 49 cardiovascular events [16] . Over the period 1984-2014, analgesic drugs, particularly NSAIDs, were the second most frequently cited drugs in spontaneous adverse drug reaction (ADR) reports in Thailand [17] . Meanwhile, only gastrointestinal side effects were often concerned and identified by patients, but other complications were less concerned [8, 18] .
Awareness of the potential side effects of NSAIDs and factors increasing their risk is important, to ensure that patients achieve optimum benefit with minimal adverse events. The provision of information is thus key when prescribing and supplying these drugs. In many countries, written information is provided with all medicines, but some studies suggest that this does not necessarily translate into increased awareness of potential risks [19, 20] . For many people, health professionals are the main source of information about medicines [21] [22] [23] [24] [25] [26] , particularly in countries where written information is less freely available, such as Thailand [27] . We have previously shown that pharmacists and physicians play a major role in providing medicines safety information to Thai patients prescribed NSAIDs [28] . However, relatively little is known about Thai patients' perceptions and knowledge of NSAID risks.
Aims of the study
In this study, we aim to determine patients' perceptions and knowledge of the risks of NSAIDs and factors affecting them.
Ethics approval
The study was approved by the Ethics Committee for Human research, Khon Kaen University. Reference number HE551130.
Methods

Study design and setting
This cross-sectional study was conducted in an 800-bed university hospital, Khon Kaen, Thailand between February 2013 and May 2013. It involved patients visiting outpatient orthopaedic clinics during the study period, and using prescribed NSAIDs for at least 1 month. A systematic random sampling method was used to select the patients, excluding patients below 18 years of age, those unable to complete the questionnaire themselves or without support to complete it.
Questionnaire development
The questionnaire, described in more detail elsewhere [28] , included demographic questions and source of information about NSAIDs and experiences of ADRs from NSAIDs, as well as knowledge and perception of NSAID risks. NSAID use was categorised as either continuous use, defined as regular use every day, or intermittent use, defined as irregular use for relief of symptoms. Risk perceptions were measured using five questions each representing an associated risk from NSAIDs: gastrointestinal system, cardiovascular system, renal system, blood pressure, and respiratory system. For each, a 100-mm Visual Analogue Scale (VAS) was used to measure the perception of NSAID risk, ranging from ''0'' (no risk) to ''10'' (maximum risk). Patients indicated their perception by making ''X'' on the 100-mm VAS line. Patients' knowledge of factors which could increase the risk of adverse events from NSAIDs was measured using a list of 11 factors which did or did not have the potential to increase risk, each with three possible answers, ''Yes'', ''No'', or ''Not sure''. The questionnaire's validity was assessed by three experts, using the index of consistency (IOC), which was 0.97 before and 0.99 after minor revisions. Pilot testing was conducted, involving 20 orthopaedic patients, to ensure readability and ease of use before data collection started.
Data collection
Every fourth patient waiting for an appointment in the outpatient clinic was approached to take part by the pharmacist researcher. Patients were asked about history of NSAID use and their medical records were accessed to confirm this. Those who had received a prescription for an NSAID for at least 1 month were asked to participate in the study and a questionnaire with information sheet explaining the purpose of the study was then given to patients who agreed. A total of 500 self-administered questionnaires were distributed by hand and returned directly to the researcher the same day.
Statistical analysis
Data from completed questionnaires were analysed using IBM SPSS for Windows (version 19.0). Baseline characteristics of patients were presented by means with standard deviation (mean ± SD), or median with interquartile range (IQR) for continuous variables, and frequency and percentage for categorical variables. The perception scores were obtained by measuring the distance on the VAS line from ''0'' with the score ranging from 0 to 10 and are reported as mean ± SD. To assess knowledge of risk factors, the score for each of the 11 questions was counted, with each correct response being given a value of one and both ''no'' or ''not sure'' being given a value of zero. The total knowledge score range was thus 0-11 points, which was then categorised into two groups based simply on the proportion of correctly identified risk factors: low-level (correct answer B 50 %, or answering 1-5 questions correctly) and high-level (correct answer [ 50 %, or answering [ 5 questions correctly). The Chi square test and independent t test were used to determine associations for categorical data and continuous data, respectively. All the independent variables for which an association was found were entered into a regression model. Binary logistic regression was used to assess factors influencing patients' knowledge of risk factors. Multiple linear regression was used to assess factors influencing patients' perceptions of NSAID risks.
Results
Response rate and demographic details
From the total 500 distributed questionnaires, 484 (96.8 %) were returned, with 474 being fully completed (94.8 %). The majority of respondents were female (N = 337, 71.1 %), more than half were educated to a low level (N = 278, 59.5 %), and the majority used an NSAID continuously or regularly (N = 330, 69.6 %) rather than intermittently or as needed. There were 107 (22.6 %) with underlying cardiovascular disease, 56 (11.8 %) with gastrointestinal disease and 37 (7.8 %) with respiratory disease. Over half (N = 270; 57.0 %) were using a gastrointestinal medicine, 40 (8.4 %) a cardiovascular medicine and 8 (1.7 %) a respiratory medicine. The median number of comorbid diseases present was 1 (IQR 0.0-1.0) and median number of concomitant medicines used was 2 (IQR 2.0-4.0). Overall, only 256 (47.1 %) claimed to have received any information about NSAID side effects.
Experiences of adverse events
Seventy-eight (16.5 %) respondents indicated that they had experienced at least one ADR from a NSAID. Patients who had experienced an ADR had more underlying diseases (median 1.0, IQR 0.0-2.0) than those who had no ADR (median 0.0, IQR 0.0-1.0) (P \ 0.001). Moreover, the occurrence of ADRs was significantly higher in patients who reported regular NSAID use (20.6 %) than in patients using them intermittently (6.9 %). Those reporting an ADR also reported shorter overall duration of NSAID use (median 2.0 months, IQR 1.0-3.0) compared to those with no ADR (median 2.5 months, IQR 1.5-4.5).
Perceptions of NSAID risks
None of the five categories of risk achieved an average scores above 5 on the VAS, indicating overall low perceptions of risk relating to NSAIDs. Patients perceived risks from NSAIDs to the renal system to be highest (4.10, IQR 0.0-5.8), followed by gastrointestinal system (2.40, IQR 0.0-4.9), however, blood pressure (0.00, IQR 0.0-1.1), cardiovascular system (0.00, IQR 0.0-0.5) and respiratory system (0.00, IQR 0.0-0.0) were perceived to be very low to no risk. There was a statistically significant difference in perceived risk level to the gastrointestinal system among non-selective users (median 3.50, IQR 0.0-5.3) and selective NSAID users (median 0.0, IQR 0.0-3.6) (P \ 0.001), but nor for other risks (Fig. 1) . However, there were no differences in perceived risk level between patients with or without experience of ADRs from NSAIDs.
Multiple linear regression was used to identify the factors affecting NSAID risk perception, but had low predictive power, being highest (19 %) for gastrointestinal risks. Regarding overall NSAID risk perception, younger patients and those who received side effect information tended to have higher perception of risk (Table 1) . In relation to individual risks, older patients and selective NSAID users perceived gastrointestinal risks to be lower, whereas those who had received information about side effects or had experienced an ADR perceived risk as higher. Educational level affected perceptions of cardiovascular and respiratory risks, while receipt of information about side effects also influenced perceptions of the risk of increased blood pressure and renal problems, but not cardiovascular risk.
Knowledge of risk factors for adverse events
Overall awareness of factors which may increase the risks of adverse events from NSAIDs is shown in Table 2 . Almost 80 % knew that long-term therapy (N = 140, 75.3 %), using a high dose (N = 151, 81.2 %), having underlying gastrointestinal problems (N = 143, 76.9 %) and renal disease (N = 149, 80.1 %) could increase the risk of adverse events. However, only around half thought the elderly had an increased risk (N = 98, 52.7 %) or that use of multiple NSAIDs was a risk factor (N = 93, 50.0 %). There was, however, much uncertainty in particular about whether anticoagulant use (N = 158, 84.9 %), smoking (N = 104, 55.9 %), hypertension (N = 100, 53.8 %) and cardiovascular disease (N = 97, 52.2 %) presented additional risk.
The mean score for all 474 patients was 5.13 ? 2.65. From logistic regression, patients with high-level knowledge scores were more likely to have underlying disease (adjusted odds ratio; OR adj 1.64, 95 %CI 1.01-2.44), and to have received side effect information (OR adj 2.02, 95 %CI 1.35-3.03), than those with low-level knowledge scores (Table 3) .
Discussion
Overall perceptions of potential risks from NSAIDs were low among this population of Thai NSAID users, with the highest perceived risk being for gastrointestinal problems, in particular among those using non-selective NSAIDs. There may be several reasons for these findings. First, nonselective NSAIDs have been available for much longer than selective agents, thus patients may have had more opportunity to receive information about their risks. This is supported by our previous study [28] , which showed that users of selective NSAIDs were less likely to receive side effect information than users of non-selective NSAID. Second, the gastro-intestinal effects of non-selective NSAIDs are widely known, hence patients may have experienced these ADRs thus may perceive this particular risk more than others. Third, healthcare professionals may be more likely to inform patients about gastrointestinal risks from NSAIDs than other risks. Previous experience of an ADR from an NSAID and educational level were related to perceptions of risk, as was receipt of information about side effects, but this varied for different risks. Knowledge of factors with potential to increase risk was also lower than desirable, but higher among those who had received some information about side effects.
Previous work in the Slovak Republic has shown low perceptions of NSAID risk among hospital in-patients, using a similar VAS score, with risk perceived as between 3.8 and 4.7 [12] . Thus our study suggests that Thai patients perceive risk to be lower. There is no ideal perception of risk score for NSAIDs. Therefore, the score suggest risk perception were minimal and indeed lower than found in previous study elsewhere using the same method. Participants in this survey were recruited using a systematic random sampling. Hence, the distribution of participants would not affect our results.
Other work shows that patients generally perceive NSAIDs as having lower levels of risk than healthcare professional [29, 30] . Studies suggest that 56 % of patients prescribed NSAIDs believe them to be safe for use [7] , but that gastrointestinal problems are the most frequently cited potential side effects followed by kidney disease [13] , similar to our findings. Provision of information about NSAID risks by physicians has been shown to be positively associated with awareness of NSAID risk among patients [10, 13] . Only around half of the patients in our study had received any information about potential side effects, whether from physicians or pharmacists. This appeared to increased risk perception in relation to gastrointestinal system, renal system and blood pressure, but not cardiovascular or respiratory conditions. Older age and lower educational level were also potential factors influencing perceptions, and have been shown elsewhere to influence risk awareness [15, 19, 31] . Awareness of underlying problems which can contribute to or increase risks from NSAIDs is important in ensuring that patients inform health professionals about these when NSAIDs are being prescribed, which may not always be the case [32] . Perhaps most important is the need to inform health professionals, whether physicians or community pharmacists, of existing NSAID use, to reduce the risk of multiple prescription. Only half the patients in our study were aware that using multiple NSAIDs increased risk of ADRs, with 45 % being uncertain. Studies suggest that multiple NSAID use is not infrequent among the general public in other countries [6, 7, 11] , however the only study on NSAID use in Thailand reported to date failed to determine whether multiple NSAIDs were used [15] .
Strengths and limitations
In this study, we used the VAS approach for measuring risk perception that has been used previously, thus enabling comparison with other work. Moreover, our study achieved a high response rate, most likely because the questionnaires were directly distributed to patients. However, the sample size was small, and it involved orthopaedic outpatients in only one university hospital and did not involve people using over the counter NSAIDs. Furthermore, a large proportion of respondents were female, hence the results may not be representative of the wider Thai population. Recall bias may also have occurred, particularly for patients who had been taking NSAIDs long-term. In addition, we classified patients' knowledge into categorical variables based only on logical assumptions.
Conclusion
Both perception of risk and knowledge of risk factors for NSAID use were very low in Thai patients. More frequent provision of side effect information could lead to better risk perception and knowledge about NSAIDs, especially among those of older age and low education level.
